Genetic models of osteochondroma onset and neoplastic progression: Evidence for mechanisms alternative to EXT genes inactivation

Oncogene

Volumn 29, Issue 26, 2010, Pages 3827-3834

  Zuntini, M ^a   Pedrini, E ^a   Parra, A ^a   Sgariglia, F ^a   Gentile, F V ^a   Pandolfi, M ^a   Alberghini, M ^a   Sangiorgi, L ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

chondrosarcoma; EXT genes; multiple osteochondroma; mutation screening; solitary osteochondroma; tumor suppressor

Indexed keywords

EXOSTOSIN 1; EXOSTOSIN 2; GLYCOPROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CANCER GROWTH; CANCER MODEL; CARCINOGENESIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE INACTIVATION; GENE INSERTION; GENETIC MODEL; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; MUTATIONAL ANALYSIS; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; OSTEOCHONDROMA; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT CANCER; SCHOOL CHILD;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE PROGRESSION; FEMALE; GENE DOSAGE; GENE SILENCING; HUMANS; MALE; MIDDLE AGED; N-ACETYLGLUCOSAMINYLTRANSFERASES; OSTEOCHONDROMA; YOUNG ADULT;

EID: 77954232044     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.135     Document Type: Article

References (33)

1. Bernard MA, Hall CE, Hogue DA, Cole WG, Scott A, Snuggs MB et al. (2001). Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes. Cell Motil Cytoskeleton 48: 149-162.
2. Bovee JV, Cleton-Jansen AM, Kuipers-Dijkshoorn NJ, van den Broek LJ, Taminiau AH, Cornelisse CJ et al. (1999a). Loss of hetero-zygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma. Genes Chrom Cancer 26: 237-246.
3. Bovee JV, Cleton-Jansen AM, Wuyts W, Caethoven G, Taminiau AH, Bakker E et al. (1999b). EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet 65: 689-698.
4. Bridge JA, Nelson M, Orndal C, Bhatia P, Neff JR. (1998). Clonal karyotypic abnormalities of the hereditary multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11-12 (EXT2) in patients with sporadic and hereditary osteochondromas. Cancer 82: 1657-1663.
5. Cheung PK, McCormick C, Crawford BE, Esko JD, Tufaro F, Duncan G. (2001). Etiological point mutations in the hereditary multiple exostoses gene EXT1: a functional analysis of heparan sulfate polymerase activity. Am J Hum Genet 69: 55-66.
6. Essadki B, Moujtahid M, Lamine A, Fikry T, Essadki O, Zryouil B. (2000). Solitary osteochondroma of the limbs. Clinical review of 76 cases and pathogenic hypothesis. Acta Orthop Belg 66: 146-153.
7. Farach-Carson MC, Hecht JT, Carson DD. (2005). Heparan sulfate proteoglycans: key players in cartilage biology. Crit Rev Eukaryot Gene Expr 15: 29-48.
8. Hall CR, Cole WG, Haynes R, Hecht JT. (2002). Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis. Am J Med Genet 112: 1-5.
9. Hameetman L, Szuhai K, Yavas A, Knijnenburg J, van Duin M, van Dekken H et al. (2007). The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions. J Natl Cancer Inst 99: 396-406.
10. Hecht JT, Hogue D, Strong LC, Hansen MF, Blanton SH, Wagner M. (1995). Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8. Am J Hum Genet 56: 1125-1131.
11. Hennekam RC. (1991). Hereditary multiple exostoses. J Med Genet 28: 262-266.
12. Huvos AG. (1991). Bone Tumors: Diagnosis, Treatment, and Prognosis, 2nd edn. WB Saunders: Philadelphia.
13. Jennes I, Pedrini E, Zuntini M, Mordenti M, Balkassmi S, Asteggiano CG et al. (2009). Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb). Hum Mutat 30: 1620-1627.
14. Knudson Jr AG. (1971). Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823.
15. Lonie L, Porter DE, Fraser M, Cole T, Wise C, Yates L et al. (2006). Determination of the mutation spectrum of the EXT1/EXT2 genes in British Caucasian patients with multiple osteochondromas, and exclusion of six candidate genes in EXT negative cases. Hum Mutat 27: 1160.
16. Ludecke H-J, Ahn J, Lin X, Hill A, Wagner M J, Schomburg L et al. (1997). Genomic organization and promoter structure of the human EXT1 gene. Genomics 40: 351-354.
17. McCormick C, Leduc Y, Martindale D, Mattison K, Esford LE, Dyer AP et al. (1998). The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nature Genet 19: 158-161.
18. McCormick C, Duncan G, Goutsos KT, Tufaro F. (2000). The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci USA 97: 668-673.
19. Mertens F, Rydholm A, Kreicbergs A, Willen H, Jonsson K, Heim S et al. (1994). Loss of chromosome band 8q24 in sporadic osteocartilaginous exostoses. Genes Chromosom Cancer 9: 8-12.
20. Pedrini E, De Luca A, Valente EM, Maini V, Capponcelli S, Mordenti M et al. (2005). Novel EXT1 and EXT2 mutations identified by DHPLC in Italian patients with multiple osteochondromas. Hum Mutat 26: 280.
21. Porter DE, Simpson AH. (1999). The neoplastic pathogenesis of solitary and multiple osteochondromas. J Pathol 188: 119-125.
22. Raskind WH, Conrad EU, Chansky H, Matsushita M. (1995). Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11. Am J Hum Genet 56: 1132-1139.
23. Rohlin A, Wernersson J, Engwall Y, Wiklund L, Bjork J, Nordling M. (2009). Parallel sequencing used in detection of mosaic mutations: comparison with four diagnostic DNA screening techniques. Hum Mutat 30: 1012-1020.
24. Schmale GA, Conrad III EU, Raskind WH. (1994). The natural history of hereditary multiple exostoses. J Bone Joint Surg Am 76: 986-992.
25. Solomon L. (1964). Hereditary multiple exostosis. Am J Hum Genet 16: 351-363.
26. Springfield DS, Gebhardt MC, McGuire MH. (1996). Chondrosarco-ma: a review. Instr Course Lect 45: 417-424.
27. Traeger-Synodinos J. (2006). Real-time PCR for prenatal and preimplantation genetic diagnosis of monogenic diseases. Mol Aspects Med 27: 176-191.
28. Trebicz-Geffen M, Robinson D, Evron Z, Glaser T, Fridkin M, Kollander Y et al. (2008). The molecular and cellular basis of exostosis formation in hereditary multiple exostoses. Int J Exp Pathol 89: 321-331.
29. Wicklund CL, Pauli RM, Johnston D, Hecht JT. (1995). Natural history study of hereditary multiple exostoses. Am J Med Genet 55: 43-46.
30. Wu Y-Q, Heutink P, de Vries BBA, Sandkuijl LA, van den Ouweland AM, Niermeijer MF et al. (1994). Assignment of a second locus for multiple exostoses to the pericentromeric region of chromosome 11. Hum Mol Genet 3: 167-171.
31. Wuyts W, Ramlakhan S, Van Hul W, Hecht JT, van den Ouweland AM, Raskind WH et al. (1995). Refinement of the multiple exostoses locus (EXT2) to a 3-cM interval on chromosome 11. Am J Hum Genet 57: 382-387.
32. Wuyts W, Van Hul W, De Boulle K, Hendrickx J, Bakker E, Vanhoenacker F et al. (1998). Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses. Am J Hum Genet 62: 346-354.
33. Wuyts W, Van Hul W. (2000). Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes. Hum Mutat 15: 220-227.